Nachrichten zur Moderna Inc. Aktie

Moderna short-sellers stare at record one-day loss as shares surge on vaccine data

Investors betting against shares of Moderna faced record one-day losses on Wednesday as the biotech companys stock more than doubled…

Moderna: Erfolgreiche Studiendaten zum personalisierten Krebsimpfstoff lösen Kursanstieg um 100 % aus!

Erfolgreiche Phase-3-Studie INTerpath-001 mit Intismeran Autogene treibt den Kurs um 100 % in die Höhe. Signifikante RFS- und DMFS-Verbesserungen…

Market movers: Moderna, Marvell, Lowes, Grey Matters...

…

Stocks making the biggest moves premarket: Moderna, Lowes, Estee Lauder & more

These are the stocks posting the largest moves premarket.…

Merck, Moderna say melanoma skin cancer vaccine meets goals in large trial

Merck and Moderna said on Wednesday a study of a personalized mRNA vaccine combined with the immunotherapy drug Keytruda reduced…

Moderna shares soar as mRNA cancer vaccine succeeds in late-stage trial

Moderna Inc (NASDAQ:MRNA, XETRA:0QF) and Merck & Co Inc (NYSE:MRK, XETRA:6MK) said Wednesday their personalized mRNA cancer vaccine, intismeran, combined...…

Dow rises as bond yields ease, Canada tariff pause lifts sentiment

10:00am: Moderna surges Wall Street is showing signs of relief on Wednesday, with the Dow Jones and S&P 500 moving…

Moderna or Merck: Which Soaring Cancer Vaccine Stock Is the Better Buy?

Shares of Moderna (MRNA) and Merck (MRK) are soaring Wednesday after the companies reported a potentially historic breakthrough for their…

Earnings, Cancer Vaccine, Long-Term Liquidity: A Busy Pre-Market

Q2 retail earnings continue, Moderna sees positive Phase 3 results, and the Treasury lowers the longer-term bond rate.…

From COVID to Cancer: Moderna Scores Melanoma Breakthrough

By successfully applying individualized mRNA technology to train the immune system against recurring tumor cells, Moderna and Merck have opened…

Moderna (MRNA) Q2 2026 Earnings Call Transcript

Net loss improved 5% on international partnerships and manufacturing gains.…

FDA Approval Of Moderna’s mRNA Flu Vaccine Is Great News. Here’s Why

The FDA’s approval is welcome news, and will hopefully open the door to much faster production of an effective vaccine…

Stocks making the biggest moves premarket: Zillow, Peloton, Sandisk, Moderna & more

These are the stocks posting the largest moves in the premarket.…

Moderna, Inc. 2026 Q2 - Results - Earnings Call Presentation

…

Moderna begins first human trial of Bundibugyo Ebola vaccine

Moderna on Tuesday said it has begun its first human trial of an experimental vaccine to protect against Bundibugyo ebolavirus,…

Stocks making the biggest moves premarket: Replimune, Chevron, Apple, Amazon, Moderna & more

These are the stocks posting the largest moves premarket.…

Moderna (MRNA) Reports Q2 Loss, Tops Revenue Estimates

Moderna (MRNA) delivered earnings and revenue surprises of 0.00% and +14.49%, respectively, for the quarter ended June 2026. Do the…

MRNA Q2 Earnings Meet, Stock Down on Norovirus Vaccine Setback

Modernas Q2 revenue tops estimates, but shares fall after its phase III norovirus vaccine study misses early success criteria.…

Moderna: A Stock to Watch or a Risky Bet?

Could Moderna be the next big opportunity in biotech? Join our experts as they dissect the companys strengths and weaknesses,…

Moderna Is Up 109% in 2026. Jim Cramer Just Called It Finally Investable Again. Is the Stock a No-Brainer Buy on Its Recent Pullback?

A fresh era of earnings growth may be on the horizon.…

Moderna (MRNA) Suffers a Larger Drop Than the General Market: Key Insights

In the most recent trading session, Moderna (MRNA) closed at $59.49, indicating a -3.77% shift from the previous trading day.…

Moderna set for uneventful Q2 report ahead of key data readouts, says Jefferies

Moderna Inc (NASDAQ:MRNA, XETRA:0QF) is expected to report second quarter results on July 31, with investors focused on the impact…

Is it easier to become a stock picker in a stock pickers market?????

A few charts I saw recently had me thinking about the challenge of trading individual stocks to generate above-average returns.The…

Moderna Aktie: Trendbruch als nächste Zündstufe?

Düsseldorf (www.aktiencheck.de) - Moderna-Chartanalyse von HSBC Trinkaus & Burkhardt:Die Analysten von HSBC Trinkaus & Burkhardt nehmen in einer aktuellen Aktienanalyse…

Moderna (MRNA) Outpaces Stock Market Gains: What You Should Know

Moderna (MRNA) closed at $81.76 in the latest trading session, marking a +2.51% move from the prior day.…

Moderna Is Up More Than 70% in a Month After a 9-0 FDA Vote. Wall Streets Average Price Target Says It Should Fall 44%. What Gives?

When a stock and the analysts covering it disagree this sharply, one of them is about to be wrong.…

Moderna vs. Recursion: Which Cutting-Edge Pharma Stock Is a Better Buy in 2026?

Moderna expands beyond vaccines while Recursion bets on AI-driven drug discovery, each with distinct risks, partnerships, and financial profiles.…

MRNA Stock on the Move: What Sparked the 33.5% Jump in the Past Week?

Moderna surges 33.5% after the company outlines plans to expand its mRNA platform beyond vaccines into oncology, autoimmune diseases and…

Jim Cramer turns bullish on health care stock after years of doubt

For most of the past three years, Jim Cramer kept his distance from Moderna, treating the biotech stock with skepticism…

Moderna, Eli Lilly & Co. auf Rekordkurs: Warum Anleger zunehmend auf Healthcare-Aktien setzen

Eli Lilly, AbbVie und Moderna erreichen vor dem Wochenende neue Höchststände Moderna stärkster Tagesgewinn im S&P 500: Moderne mRNA-Strategie…

Stocks making the biggest moves midday: Moderna, ON Semiconductor, Rocket Lab, Eli Lilly, Sandisk & more

Here are the companies making headlines in midday trading.…

Moderna, Inc. (MRNA) Discusses Advancements in mRNA Technology, Clinical Modalities, and Future Horizons in Science Transcript

…

dpa-AFX ProFeed